134 related articles for article (PubMed ID: 33758998)
1. Opioids are not a major cause of death of patients with sickle cell disease.
Ballas SK
Ann Hematol; 2021 May; 100(5):1133-1138. PubMed ID: 33758998
[TBL] [Abstract][Full Text] [Related]
2. Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017.
Payne AB; Mehal JM; Chapman C; Haberling DL; Richardson LC; Bean CJ; Hooper WC
Ann Emerg Med; 2020 Sep; 76(3S):S28-S36. PubMed ID: 32928459
[TBL] [Abstract][Full Text] [Related]
3. Sickle cell disease related mortality in the United States (1999-2009).
Hamideh D; Alvarez O
Pediatr Blood Cancer; 2013 Sep; 60(9):1482-6. PubMed ID: 23637037
[TBL] [Abstract][Full Text] [Related]
4. Autopsy findings and pattern of mortality in Nigerian sickle cell disease patients.
Ogun GO; Ebili H; Kotila TR
Pan Afr Med J; 2014; 18():30. PubMed ID: 25368719
[TBL] [Abstract][Full Text] [Related]
5. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome.
Nnoli A; Seligman NS; Dysart K; Baxter JK; Ballas SK
J Natl Med Assoc; 2018 Apr; 110(2):163-168. PubMed ID: 29580450
[TBL] [Abstract][Full Text] [Related]
6. Characterization of opioid use in sickle cell disease.
Han J; Zhou J; Saraf SL; Gordeuk VR; Calip GS
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):479-486. PubMed ID: 28815799
[TBL] [Abstract][Full Text] [Related]
7. Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008.
Paulukonis ST; Eckman JR; Snyder AB; Hagar W; Feuchtbaum LB; Zhou M; Grant AM; Hulihan MM
Public Health Rep; 2016; 131(2):367-75. PubMed ID: 26957672
[TBL] [Abstract][Full Text] [Related]
8. Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.
Rudd RA; Aleshire N; Zibbell JE; Gladden RM
MMWR Morb Mortal Wkly Rep; 2016 Jan; 64(50-51):1378-82. PubMed ID: 26720857
[TBL] [Abstract][Full Text] [Related]
9. Mortality rates and age at death from sickle cell disease: U.S., 1979-2005.
Lanzkron S; Carroll CP; Haywood C
Public Health Rep; 2013; 128(2):110-6. PubMed ID: 23450875
[TBL] [Abstract][Full Text] [Related]
10. National trends in hydroxyurea and opioid prescribing for sickle cell disease by office-based physicians in the United States, 1997-2017.
Su ZT; Segal JB; Lanzkron S; Ogunsile FJ
Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1246-1250. PubMed ID: 31328369
[TBL] [Abstract][Full Text] [Related]
11. Age-related prescription medication utilization for the -management of sickle cell disease among Texas Medicaid patients.
Shukla N; Barner JC; Lawson KA; Rascati KL
J Opioid Manag; 2021; 17(4):301-310. PubMed ID: 34533824
[TBL] [Abstract][Full Text] [Related]
12. Mortality of children with sickle cell disease: a population study.
Fernandes AP; Januário JN; Cangussu CB; Macedo DL; Viana MB
J Pediatr (Rio J); 2010; 86(4):279-84. PubMed ID: 20508908
[TBL] [Abstract][Full Text] [Related]
13. Pain in sickle cell disease: current and potential translational therapies.
Sagi V; Mittal A; Tran H; Gupta K
Transl Res; 2021 Aug; 234():141-158. PubMed ID: 33711512
[TBL] [Abstract][Full Text] [Related]
14. Weight Loss as an Effective Strategy to Decrease Opioid Use and Frequency of Vaso-Occlusive Crises in Patients with Sickle Cell Disease.
Babroudi S; Vesel T
J Palliat Med; 2021 Apr; 24(4):632-634. PubMed ID: 32881637
[No Abstract] [Full Text] [Related]
15. COVID-19 and Sickle Cell Disease-Related Deaths Reported in the United States.
Payne AB; Schieve LA; Abe K; Hulihan M; Hooper WC; Hsu LL
Public Health Rep; 2022; 137(2):234-238. PubMed ID: 35060794
[TBL] [Abstract][Full Text] [Related]
16. Mortality and Causes of Death From Sickle Cell Disease in The Netherlands, 1985-2017.
Rettenbacher E; Zaal J; Heijboer H; van der Plas EM; Hof M; Biemond BJ; Fijnvandraat K;
J Pediatr Hematol Oncol; 2021 Oct; 43(7):258-265. PubMed ID: 34001787
[TBL] [Abstract][Full Text] [Related]
17. Inpatient use of laxatives during opioid administration in children with sickle cell disease.
O'Brien SH; Fan L; Kelleher KJ
Pediatr Blood Cancer; 2010 Apr; 54(4):559-62. PubMed ID: 20049931
[TBL] [Abstract][Full Text] [Related]
18. Patterns of mortality in sickle cell disease in adults in France and England.
Perronne V; Roberts-Harewood M; Bachir D; Roudot-Thoraval F; Delord JM; Thuret I; Schaeffer A; Davies SC; Galactéros F; Godeau B
Hematol J; 2002; 3(1):56-60. PubMed ID: 11960397
[TBL] [Abstract][Full Text] [Related]
19. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
20. Clinical analysis of mortality in hospitalized Zambian children with sickle cell anaemia.
Athale UH; Chintu C
East Afr Med J; 1994 Jun; 71(6):388-91. PubMed ID: 7835262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
